Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lotus Clinical Research has conducted over 500 clinical trials since its founding in acute and chronic pain models and has contributed to at least ten FDA analgesic approvals. The company’s innovations include industry-standard placebo response mitigation programs and standardized abdominoplasty models for soft tissue postsurgical pain studies. It provides end-to-end scientific leadership for CNS/metabolic drug development with a focus on operational efficiency via its integration with Evolution Research Group’s site network.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lotus Clinical Research.